Schedule 13G ownership disclosure
Intellia Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 45826J105
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- THE GOLDMAN SACHS GROUP, INC.
Shares: 3,157,178.33 · Class: 2.7%
- GOLDMAN SACHS & CO. LLC
Shares: 3,157,178.33 · Class: 2.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000886982-26-000085
- Form type
- SCHEDULE 13G/A
- Filer
- GOLDMAN SACHS GROUP INC
- CIK
- CIK 886982
- Filed
- Feb 12, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership